Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Zealand Pharma - Transactions related to share buy-back program (week 38, 2026)
Zealand Pharma - Transactions related to share buy-back program (week 38, 2026)
GlobeNewswire

Company announcement No. 49 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 38, 2026) Copenhagen, Denmark, September 21, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

rediff.com - Sohini Das - India's Top 10 Pharma Companies Sustain Volume Growth, Outperforming Smaller Rivals
India's Top 10 Pharma Companies Sustain Volume Growth, Outperforming Smaller Rivals
Rediff.com

India's leading pharmaceutical companies are consistently outperforming their smaller counterparts in volume growth, driven by strategic advantages and a significant market shift towards high-value chronic and sub-chronic therapies. India's top 10…

bloomberg.com - Angel Adegbesan - Drugmaker Adarx Pharma Seeks to Raise $371.9 Million in US IPO
Drugmaker Adarx Pharma Seeks to Raise $371.9 Million in US IPO
Bloomberg

Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, is seeking to raise as much as $371.9 million in a US initial public offering. The San Diego-based firm, which counts OrbiMed Advisors as a backer, plans to market 21.875 million…

thehindubusinessline.com - Broker's Call: Sun Pharma (Buy)
Broker's Call: Sun Pharma (Buy)
BusinessLine

Sun Pharmaceutical is India's largest pharmaceutical company and a leading global specialty generics company. It develops, manufactures and markets branded and generic formulations and active pharmaceutical ingredients. In Q1FY27, consolidated…

wsj.com - Xavier Martinez - Pharmaceutical Companies Push Trump Administration to Protect China Deals
Pharmaceutical Companies Push Trump Administration to Protect China Deals
Wall Street Journal

Western pharmaceutical companies are urging the administration to allow them to keep doing deals with Chinese companies for promising drug candidates, despite a 2025 law restricting U.S. investment in Chinese technology. The group that represents…

forbes.com - Nataliya Andreychuk - The New Rules Of Trust: Why Credentials Alone No Longer Win The Room
The New Rules Of Trust: Why Credentials Alone No Longer Win The Room
Forbes

Nataliya Andreychuk is the CEO of Viseven. She is a leading digital transformation evangelist for the pharma and life sciences industries. ​In the past few years, trust has started to feel so different from what we were used to before. I've…

rediff.com - Nandita Malik - Sensex, Nifty Pare Early Gains Despite Global Markets' Rally, Easing Crude Prices
Sensex, Nifty Pare Early Gains Despite Global Markets' Rally, Easing Crude Prices
Rediff.com

Indian benchmark indices Sensex and Nifty opened higher on global market rally and easing crude oil prices but pared gains and are trading in red. Indian benchmark indices Sensex and Nifty recorded gains in early trade, continuing their upward…

axios.com - Caitlin Owens - Midterms' new populism: Taking on health industries
Midterms' new populism: Taking on health industries
Axios

The willingness to confront powerful health care interests is becoming a litmus test for candidates in congressional battleground races with six weeks to go before the midterm elections. Why it matters: Forget the old Affordable Care Act wars.

medpagetoday.com - Rachael Robertson - Meet This Year's Forbes Healthcare Billionaires
Meet This Year's Forbes Healthcare Billionaires
Medpage Today

Fifteen of the 400 richest people in America made their fortunes in healthcare -- and four of them are physicians, according to Forbes ' annual ranking. At the top of the pack is Thomas Frist Jr., MD, and his family, whose net worth is a whopping…

cnbc.com - Sawdah Bhaimiya - Novo CEO signals M&A opportunities to strengthen drug pipeline
Novo CEO signals M&A opportunities to strengthen drug pipeline
CNBC

Novo CEO Mike Doustdar told CNBC the company was mulling M&A opportunities amid increasing competition. He was speaking the day after the Danish pharma giant's stock fell nearly 8%, after a turnaround plan failed to placate investors. Michael Nagle…

thehindu.com - Pti - Stock markets rise in early trade amid rally in global peers, easing crude oil prices
Stock markets rise in early trade amid rally in global peers, easing crude oil prices
The Hindu

Benchmark indices Sensex and Nifty were trading higher in early trade on Tuesday (September 22, 2026) following a rally in global markets and easing crude oil prices. The 30-share BSE Sensex was up 42.51 points to 74,901.50 in opening trade. The…

science20.com - Hank Campbell - That Medical Supplement Ad May Be A Deepfake AI Doctor
That Medical Supplement Ad May Be A Deepfake AI Doctor
Science 2.0

Once upon a time, suspect supplement salespeople who wanted to get rich had to be on the Oprah TV show or be friends with President Clinton. Not now. Drs. Oz, Chopra, Hyman, and Weil, or anyone who wants to take their place in the Four Horsemen of…

pagalparrot.com - Business Desk - Sensex adds 564 points after six weekly falls, but the breadth was negative
Sensex adds 564 points after six weekly falls, but the breadth was negative
PagalParrot

Markets Nifty at 23,414.30. Pharma, FMCG and realty led while midcaps and smallcaps lagged, which is what bargain buying looks like. The Sensex closed 564.03 points higher at 74,858.99 and the Nifty added 67.90 to 23,414.30 — the first real…

cnbc.com - Anniek Bao - CNBC Daily Open: All that glitters is another U.S.-China détente
CNBC Daily Open: All that glitters is another U.S.-China détente
CNBC

AI-linked stocks powered another rally on Wall Street, with equities climbing as oil prices and Treasury yields both slipped. Bitcoin pushed above $86,000 on Monday, briefly touching $86,349.90, its highest level since late January. A slew of U.S.

globenewswire.com - Abivax - Abivax Presents Business Updates and First Half 2026 Financial Results
Abivax Presents Business Updates and First Half 2026 Financial Results
GlobeNewswire

Abivax Presents Business Updates and First Half 2026 Financial Results Chris Rabbat to succeed Fabio Cataldi as Chief Medical Officer; Tim Kelly appointed Chief Technical Officer to advance commercial supply readiness and lead Abivax's Chemistry…

Receive a Daily briefing on Pharma Industry News

Get Started